Chemcon Speciality Chemicals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.

EBITDA margin compressionRelated-party transactionsResults View source PDF Explain this filing

CHEMCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-6.1%Reaction day

₹187.00

prior close

₹181.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.5%-4.7% vs market

Specialty Chemicals peers, median of 86sector-1.5%-4.7% vs sector

On the reaction day the stock moved 4.7 pts less than Nifty Microcap 250 and 4.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.4

10m

-2.9

15m

-3.4

30m

-3.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-6.1-1.5-4.7-1.5-4.7

Next day

-8.2-2.2-6.0-2.8-5.4

-4.9-1.2-3.6-2.3-2.5

-6.3-0.9-5.4-1.6-4.7

-8.6-2.3-6.2-2.9-5.7

-9.1-2.5-6.6-2.9-6.2

-12.3-3.6-8.7-3.5-8.8

15d

-18.2-10.4-7.8-10.3-7.9

-19.2-11.3-7.9-11.0-8.2

-19.5-3.6-16.0-5.5-14.0

-9.4+3.9-13.2+1.3-10.7

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 86Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Chemcon Speciality Chemicals reported Q3 FY26 revenue of ₹57.32 crore, up about 5.4% year-on-year, but net profit fell sharply to ₹5.09 crore from ₹8.81 crore, a decline of roughly 42%. The profit drop was driven mainly by a steep jump in finance costs (₹2.82 crore vs ₹0.74 crore in Q3 last year), pointing to fresh debt on the books. For the nine months ended December 2025, revenue rose 7.9% to ₹164.56 crore, while net profit slipped around 16% to ₹17.23 crore. The company also disclosed a ₹36 crore slump-sale acquisition of Shivam Petrochem Industries, a related-party partnership firm, effective October 2025. Auditor Shah Mehta & Bakshi issued an unmodified limited review report with no qualifications.

Likely market impact

Topline growth is positive, but sharply higher finance costs have crushed profitability, signalling meaningful margin compression and likely new borrowings—possibly linked to the related-party acquisition. Shareholders should watch for clarity on the debt taken for the Shivam Petrochem deal and any future margin recovery.